Shows / New Retina Radio by Eyetube
New Retina Radio by Eyetube
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Episodes
New Retina Radio by EyetubeNew Retina Radio Journal Club: Medical Management of Macular Holes
As more data are published regarding medical intervention for macular hole closure, retina specialists want to know which patients are best suited for this…
- New Retina Radio by Eyetube
The Latest on Gene Therapy for Inherited Retinal Diseases
In this roundtable moderated by Allen C. Ho, MD, IRD experts discuss their experiences treating patients with voretigene neparvovec (Luxturna, Spark), tips and…
New Retina Radio by EyetubeAAO 2021: PALADIN for DME and ROP Updates From the ICROP
Extending treatment duration in patients with DME whose disease is responsive to steroid therapy could be instrumental in ensuring that visual disruption is…
New Retina Radio by EyetubeAAO 2021 Late Breakers: DAVIO and NORSE-2
Is a technology that inhibits tyrosine kinase and shows activity against all isoforms of VEGF and placental growth factor the future of wet AMD therapy? Data…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Biosimilars in Wet AMD
The biosimilars are coming—and studies about them are starting to fill the literature. One such study is the COLUMBUS-AMD study, which evaluated the clinical…
New Retina Radio by EyetubeAAO 2021: Protocol W and Monitoring for Wet AMD
Can anti-VEGF agents act as effective prophylactic treatment for diabetic patients with a high risk of developing diabetic eye disease? Data from the Protocol…
New Retina Radio by EyetubeAAO 2021 Late Breakers: GATHER1 and ALTISSIMO
Knowing at which point in the course of disease progression a drug for geographic atrophy could be most effective may be key to unlocking a treatment paradigm…
- New Retina Radio by Eyetube
Developing an innovative drug delivery system for nAMD
The treatment landscape for nAMD has expanded to include a refillable, intraocular device that continuously delivers therapy. What was the inspiration behind…
New Retina Radio by EyetubeInternational Perspectives on ROP
How do the latest data and treatment guidelines inform treatment strategies for retinopathy of prematurity (ROP) among European and Latin American retina…
New Retina Radio by EyetubeLuminaries in Retina: Kirk Packo, MD, FACS (Part 2)
In part 2 of this special podcast interview with John W. Kitchens, MD, and Kirk Packo, MD, FACS, they dive into Dr. Packo's involvement in the creation of AAO…
New Retina Radio by EyetubeLuminaries in Retina: Kirk Packo, MD, FACS (Part 1)
In this new podcast episode, John W. Kitchens, MD, interviews Kirk Packo, MD, FACS, around his triumphant career and his decision to retire from practicing…
New Retina Radio by EyetubeASRS 2021: The Pipeline for Wet AMD and GA
The pipeline in retina is bursting! Which datasets shared at the ASRS 2021 meeting provided insights into the future of retina? Mark Barakat, MD, joins the…
New Retina Radio by EyetubeASRS 2021: Losing GA Patients to Follow-up and DME Meta-analysis
The age of big data allows researchers to uncover how real-world patients with geographic atrophy (GA) behave. What did a deep dive into the IRIS Registry…
New Retina Radio by EyetubeASRS 2021: ARCHWAY and TENAYA/LUCERNE
We may be on the cusp of the next great era of wet AMD therapy. Which phase 3 data will guide physician decision-making if new technologies are approved by…
New Retina Radio by EyetubeVitreous Opacities: How ODs and MDs Can Collaborate
How can retina surgeons work with optometrists to create a framework that best manages the cases of patients with vitreous opacities? To answer this question…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Treating CMV with Adoptive Immunotherapy
Cytomegalovirus (CMV) retinitis continues to challenge retina specialists. Could use of CMV-specific cytotoxic T lymphocytes be an effective strategy in some…
New Retina Radio by EyetubeInternational Perspectives: RVO
In the next installment of the New Retina Radio miniseries "International Perspectives," moderator Jennifer Arnold (Australia) in joined by panelists Ramin…
New Retina Radio by EyetubeVitreous Opacities: Hearing from Anterior and Posterior Segment Surgeons
It isn't often that anterior segment and posterior segment surgeons discuss surgery. New Retina Radio, in a crossover episode with CRST: The Podcast, is…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Exudative AMD in FILLY and GATHER1 Results
As retina inches closer to a therapy that is safe and effective for the treatment of GA in the presence of dry AMD, the VBS Journal Club meets to review a pair…
New Retina Radio by EyetubeThe Art of Drug Choice: International Panel in Wet AMD: Safety Data
Safety will ultimately drive decision-making for patients with wet AMD. What are the latest safety data in the MERLIN, ARCHWAY, OPTIC, RGX-314, and…
New Retina Radio by EyetubeVitreous Opacities: Innovations and the Decision to Operate
Perspectives regarding surgery for vitreous opacities (VOs) have shifted in the past several years. How have innovations in surgical instrumentation…
New Retina Radio by EyetubeThe Art of Drug Choice: International Panel in Wet AMD: The Pipeline
The pipeline of wet AMD treatments is inspiring. What can retina specialists around the world expect when it comes to wet AMD therapy candidates KSI-301…
New Retina Radio by EyetubeInternational Perspectives: DME
In this opening installment of the New Retina Radio miniseries "International Perspectives," moderator Patricio Schlottmann (Argentina) sits down with…
New Retina Radio by EyetubeThe Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch
If new treatment options for wet AMD are approved for treatment, retina specialists will have even more options to switch patients to a new therapy. Which drug…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Data in the Wake of COVID-19
As the threat of COVID-19 subsides, scientists are working to make sense of the information that was gathered during the pandemic. Caroline Baumal, MD, asks M…
New Retina Radio by EyetubeThe Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes Sense
Retina specialists around the world aim to reduce treatment burden while maximizing therapeutic outcomes in patients. How do global experts decide when to…
New Retina Radio by EyetubeSurgical options for treating AMD: Clinical Implications and Impact
In the third episode of the Missing Link podcast series, Carl D. Regillo, MD, speaks with Carl Awh, MD, and Dante Pieramici, MD, about surgical options for…
- New Retina Radio by Eyetube
Advances in Gene Therapy for Wet AMD
In this roundtable moderated by Allen C. Ho, MD, experts in gene therapy discuss the latest data, clinical trial hurdles, and the promise these programs hold…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Masking in Retina: Keeping Patients Safe from Bacterial Exposure
Masks are effective in curbing transmission of COVID-19. But could they also direct bacteria toward the ocular region? Yoshi Yonekawa, MD, hears from two…
New Retina Radio by EyetubeReconsidering treatment endpoints in real-world clinical practice: is achieving a favorable retreatment interval a goal of therapy?
In the second episode of the Missing Link podcast series, Carl D. Regillo, MD, speaks with Jennifer Lim, MD, and Charlie Wykoff, MD, PhD, about the challenges…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Autologous Retina Transplant for Macular Holes
How effective is the use of autologous retina transplant for the treatment of macular holes? Caroline Baumal, MD, moderates a panel comprised of M. Ali Khan…
New Retina Radio by EyetubeReal-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patients
In this episode of the Missing Link podcast series, Carl D. Regillo, MD, speaks with Margaret Chang, MD, and David Eichenbaum, MD, about the consequences of…
New Retina Radio by EyetubeARVO 2021 Coverage: NGM621 and COOG2
C3 is a possible target in patients with geographic atrophy. What do the latest data from ARVO tell us about the safety and tolerability of NGM621, a drug…
New Retina Radio by EyetubeARVO 2021: GATHER1 Study and CME After RRD Surgery
18-month results for GATHER1 look promising, but another pivotal study is still in the works. What else needs to happen for Zimura to become the first…
New Retina Radio by EyetubeARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?
The phase 3 TENAYA and LUCERNE trials, which assessed the safety and efficacy of faricimab for wet AMD therapy, have wrapped up. What did the researchers…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Protocol W: How Might the Data Change Practice?
Need a refresher on Protocol W, the latest study from the DRCR Retina Network? Yoshi Yonekawa, MD, invites VBS members Ajay Kuriyan, MD; Anton Orlin, MD; and…
New Retina Radio by EyetubeNew Retina Radio Journal Club: PRO Study Group Papers: Part 2
In the second part of this two-part series on literature in retinal detachment surgery, moderator Jay Sridhar, MD, is joined by panelists Brian Do, MD; Sabin…
New Retina Radio by EyetubeNew Retina Radio Journal Club: PRO Study Group Papers: Part 1
In the first part of this two-part series reviewing reports from the Primary Retinal Detachment Outcomes Study Group, moderator Jay Sridhar, MD, invites…
New Retina Radio by EyetubeAngiogenesis 2021: Early Phase Data
Early phase data sets are one of the stars of the Angiogenesis, Exudation, and Degeneration annual meeting. Which presentations are worth a second look? John…
New Retina Radio by EyetubeAngiogenesis 2021: Wet AMD
Which upcoming therapies will extend duration for patients with wet AMD? John Kitchens, MD, sits down with Diana Do, MD, and Carl Regillo, MD, to hear about…
New Retina Radio by EyetubeNew Retina Radio Journal Club: OCT Biomarkers in New Onset GA
Can OCT be used to detect areas at risk for GA progression in patients with intermediate AMD? Yoshihiro Yonekawa, MD, invites Marion Munk, MD, PhD; Lejla…
New Retina Radio by EyetubeAngiogenesis 2021: Geographic Atrophy
How close are retina specialists to offering an effective therapy for patients with geographic atrophy secondary to dry AMD? John Kitchens, MD, hears summaries…
- New Retina Radio by Eyetube
Let’s Talk Diversity and Inclusion
In this roundtable hosted by María H. Berrocal, MD, and Audina M. Berrocal, MD, new department chairs in retina share their journeys to leadership and how to…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Anti-VEGF vs Surgery + PRP for VH with PDR
Aleksandra Rachitskaya, MD, moderates a panel comprised of Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD, to review a study from the DRCR…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Phase 2 LADDER Study Data
Aleksandra Rachitskaya, MD, leads a discussion with Mrinali Gupta, MD; Eric Nudleman, MD, PhD; and Aris Thanos, MD, about the phase 2 LADDER study, which…
New Retina Radio by EyetubeInternational Perspectives: Digital Solutions for the Management of Amblyopia
In this podcast, Prof. Richard Harrad (UK) joins Prof. Ben Thompson (Canada) and Prof. Ann Webber (Australia) for a discussion on the use of dichoptic therapy…
New Retina Radio by EyetubeInternational Perspectives: How Will Artificial Intelligence Affect the Practice of Ophthalmology?
In this podcast, Dr Peter Kaiser (USA) leads a conversation with Prof. James Wolffsohn (UK) and Dr Pearce Keane (UK) in which they explore the use of AI…
New Retina Radio by EyetubeClinical Impacts From AAO 2020: Drs. Singh, Ehlers, and Gillies
Will data shared at AAO 2020 affect your clinical decision-making with wet AMD patients? Rishi Singh, MD, invites Justis Ehlers, MD, and Mark Gillies, MD, PhD…
New Retina Radio by EyetubeFluid in Neovascular Age-Related Macular Degeneration – Evolution of Understanding
Join Dr. Rishi Singh (USA) as he speaks with Prof. Jennifer Arnold (Australia), Prof. Mark Gillies (Australia) and Dr. SriniVas Sadda (USA) about the role and…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Imaging Modalities in DR
Host Jorge Fortun, MD, and guests Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD, review real-world data that compare widefield swept-source…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Intravitreal Dexamethasone Implant in DME Patients
Host Jorge Fortun, MD, and guests Cynthia Qian, MD; Christina Weng, MD, MBA; and Basil Williams, MD, discuss a retrospective study on the efficacy and safety…
New Retina Radio by EyetubeClinical Impacts From AAO 2020: Drs. Singh, Do, and Heier
How will data shared at AAO 2020 impact clinical decision-making in wet AMD therapy? Rishi Singh, MD, is joined by Diana Do, MD, and Jeffrey Heier, MD, to…
New Retina Radio by EyetubeDRCR Retina Network Protocol AB at AAO
DRCR Retina Network Protocol AB compared aflibercept (Eylea, Regeneron) to PPV and PRP in patients with diabetic vitreous hemorrhage. DRCR Retina Network Vice…
New Retina Radio by EyetubeAAO Late Breaker: IRIS Registry Data on GA
Tracking real-world data on geographic atrophy has been patchwork process—until now. Thanks to the AAO IRIS Registry, real-world information on eye diseases…
New Retina Radio by EyetubeCoding Changes for 2021 at AAO
In 2021, E/M codes will undergo their most significant changes since 1997. How will these changes affect your billing and coding—and what processes can you put…
New Retina Radio by EyetubeAAO Late Breaker: Ang-2 Mediation in DME Therapy
The next generation of therapy for DME patients will require looking beyond the VEGF pathway. In the phase 2 BOULEVARD study, researchers are assessing the…
New Retina Radio by EyetubeRetinal Arteriolar Macroaneurysm and Anti-VEGF Therapy at AAO
Retinal arteriolar macroaneurysm (RAM) usually regresses spontaneously, but can lead to irreversible vision loss if regression does not occur. Could anti-VEGF…
New Retina Radio by EyetubeAAO Late Breaker: KSI-301 in DME Therapy
The burden of anti-VEGF therapy is particularly high in DME patients, many of whom are young, in the workforce, and unable to easily maintain monthly therapy…
New Retina Radio by EyetubeThe Art of Drug Choice: Phase 3 Trials in Wet AMD
In episode 2 of the NRR miniseries “The Art of Drug Choice: Wet AMD and the Latest Data,” Dr. Khanani and roundtable participants Drs. Fuller, London, and Weng…
New Retina Radio by EyetubeThe Art of Drug Choice: Safety in Wet AMD
NRR’s miniseries “The Art of Drug Choice: Wet AMD and the Latest Data” wraps up with moderator Dr. Khanani and panelists Drs. Fuller, London, and Weng…